|
CN111747855A
|
|
Synthesis and resolution of nortramadol intermediates
|
|
CN111484414A
|
|
2, 4-dinitrophenol derivatives and uses thereof
|
|
CN111393496A
|
|
3-hydroxy-5-pregnan-20-one water-soluble prodrug and application thereof
|
|
CN111440086A
|
|
Salt of tranilast
|
|
CN111514105A
|
|
Pharmaceutical compositions containing JAK inhibitors
|
|
CN111499610A
|
|
Polymorphs of pomalidomide prodrug salt
|
|
CN111481544A
|
|
Pharmaceutical preparation
|
|
CN111434659A
|
|
Pomalidomide prodrug salt
|
|
CN111281877A
|
|
New formulations of neuroactive steroids
|
|
CN111040015A
|
|
19-nor-C21 substituted steroid derivatives
|
|
CN110548005A
|
|
Sustained-release injection preparation containing donepezil derivative
|
|
CN110483372A
|
|
The salt of Bupivacaine
|
|
CN110437261A
|
|
The synthetic method of bendamustine impurity G
|
|
CN110028415A
|
|
Curcumin derivate and application thereof
|
|
CN106692051A
|
|
Preparation of 17-(3-pyridine)-androst-4, 6-diene-3-one
|
